04

05

~

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver

disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (1):73-84.

2. Non-alcoholic Fatty Liver Disease Study G, Lonardo A, Bellentani S, Argo CK, Ballestri S, Byrne CD et al. (2015)

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Dig Liver Dis 47 (12):997-1006.

3. Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B et al. (2015) High Prevalence of Nonalcoholic

Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

J Clin Endocrinol Metab 100 (6):2231-2238.

4. Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M et al. (2015) Association of nonalcoholic fatty

liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology

62 (6):1723-1730.

5. Brea A, Puzo J (2013) Non-alcoholic fatty liver disease and cardiovascular risk. Int J Cardiol 167 (4):1109-1117.

6. Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G (2014) Risk of cardiovascular, cardiac and arrhythmic

complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol 20 (7):1724-1745.

7. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M et al. (2014) Association of non-alcoholic

fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 11 (7):e1001680.

8. Marcuccilli M, Chonchol M (2016) NAFLD and Chronic Kidney Disease. Int J Mol Sci 17 (4):562.

9. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L et al. (2007) Prevalence of nonalcoholic fatty liver

disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30 (5):1212-1218.

06